Skip to content
Intrinsic value · Buy/Sell verdict · scores — free· 500 Nifty 500 stocks· EOD 2026-06-15

Mangalore Refinery & Petrochemicals Ltd.

MRPL · NSE · Energy

₹168.95
+7.94 (+4.93%)
Our verdict
Sell38/100
Quality29
Valuation55
Momentum56
Financial trend7
Intrinsic value
Our fair value
₹169.08
Fairly valued
Price ₹168.95Range ₹143.72₹194.45

With a 20% margin of safety, our buy-below price is ₹135.27.

C
Financial health 51/100
Altman Z 3.03 · Safe zone

Piotroski F-score 6/9 — quality of earnings & balance sheet.

Investability checklist

Passed 4 of 13 checks31/100
  • ROE above 15%14.2%
  • Low debt (D/E < 0.5)1.08x
  • Positive free cash flow
  • Revenue growth > 10%-3%
  • Earnings growing-68%
  • Net margin ≥ 10%2.2%
  • Current ratio > 1.51.14
  • Below our fair value
  • Margin of safety ≥ 20%
  • Above 200-day average
  • Above 50-day average
  • Positive 1-year return
  • Altman Z in safe zoneZ 3.03
  • Piotroski ≥ 76/9

1-year price

EOD · 2026-06-15
1W
+11.5%
1M
+12.4%
3M
-11.7%
6M
+12.3%
1Y

Our scores

Durability29
Valuation59
Momentum56
Analyst consensus target ₹179 (+6%) · 2 analysts

Key fundamentals

Market cap
₹29,610 Cr
P/E ratio
15.4
P/B ratio
2.08
EPS (TTM)
₹10.98
ROE
14.2%
Debt / Equity
1.08x
Profit margin
2.2%
Free cash flow
₹-524 Cr
52-week high
₹206.77
-18.29% from high
52-week low
₹119.14
Dividend yield
2.5%
Beta
0.18

SWOT snapshot

Strengths

  • Financially solid — Altman Z 3.03.

Threats

  • Earnings contracting year on year.

About Mangalore Refinery & Petrochemicals Ltd.

Mangalore Refinery and Petrochemicals Limited engages in the manufacture and sale of refined petroleum products in India. The company produces and sells bitumen, Xylol, high speed diesel, xylol, pet coke, sulphur, and motor gasoline, as well as polypropylene and other products. It also sells petrochemical products, such as aromatic products comprising paraxylene, benzene, heavy aromatics, paraffinic raffinate, reformate, and toluene

More in Oil Gas & Consumable Fuels

Our verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.